Full name
SANOPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.20.Z - Manufacture of medicines and other pharmaceutical products
10 - Manufacture of food products
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade, except of motor vehicles and motorcycles
47 - Retail trade, except motor vehicle retail
70.2 - Management consultancy activities
73 - Advertising and market research
77 - Rental and leasing activities
82.99.Z - Other business support service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,5 | 1,1 | 0,3 | -73,5 |
EBITDA | 1,6 | 1,2 | 0,3 | -74 |
Short time liabilities | 0,2 | 0,4 | 0,1 | -75,9 |
Equity capital | 1,6 | 2,4 | 2,6 | 11,2 |
Operating profit (EBIT) | 1,5 | 1,2 | 0,3 | -72,9 |
Assets | 1,9 | 2,9 | 2,8 | -0,3 |
Net profit (loss) | 1,4 | 1 | 0,3 | -74,3 |
Cash | 0,8 | 1,5 | 1,9 | 28,5 |
Liabilities and provisions for liabilities | 0,3 | 0,5 | 0,2 | -57,7 |
Net income from sale | 2,5 | 2,3 | 1,6 | -29,3 |
Working assets | 1,4 | 2,6 | 2,5 | -0,7 |
Depreciation | 0,1 | 0,1 | 0 | -90,3 |
% | % | % | p.p. | |
Profitability of capital | 85,4 | 43,4 | 10,1 | -33,3 |
Equity capital to total assets | 83,5 | 83,3 | 92,9 | 9,6 |
Gross profit margin | 59,6 | 49,5 | 18,6 | -30,9 |
EBITDA Margin | 62,5 | 53,6 | 19,7 | -33,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 32 | 60 | 20 | -40 |
Current financial liquidity indicator | 6.121383190155029 | 6.768433094024658 | 27.87958526611328 | 21,1 |
Net dept to EBITDA | -0.45793697237968445 | -1.1364270448684692 | -5.669102191925049 | -4,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane